Before COVID-19, Zimbabwe’s health sector was already facing shortages of resources, medicines, and had weak supply chains. The country also had problems getting foreign currency, which made buying needed medical supplies harder. When COVID-19 began, these issues got worse because global supply chains struggled to source, make, and ship important health items like medicines and personal protective equipment (PPE).
Many restrictions appeared, such as export bans and limits on movement. These made it hard for Zimbabwe to get shipments from other countries. Because of this, prices for imported medicines and PPE went up a lot. Higher freight costs and fewer overseas suppliers joining bidding processes made it even harder to get these products.
Some effects were less serious because there was an unexpected drop in patients and less use of health services during peak times of the pandemic. But overall, Zimbabwe’s healthcare supply system showed how weak it was and revealed the need for new ways to keep access to essential products during crises.
Pooled procurement is when several buyers, like hospitals, clinics, or countries, combine their buying power to purchase medical products together. This helps get better prices, keeps supplies steady, lowers shipping problems, and protects against shortages during emergencies.
For Zimbabwe, pooled procurement was recommended to reduce price swings and make medicines more available by working together at regional and global levels. By teaming up, health groups could place bigger orders, encourage competition among suppliers, and guard against export limits that often happen in global health crises.
In practice, pooled procurement means putting orders together with trusted suppliers and signing contracts for several years to secure future supplies. This lowers guesswork in demand planning, smooths out price changes, and makes medical product purchasing more stable.
Although the U.S. has a more developed healthcare system, it still faced supply chain shocks during the COVID-19 pandemic. U.S. hospitals had PPE shortages, late deliveries of important medicines, and price increases. These problems were like what happened in Zimbabwe but on a different scale.
During the pandemic, Zimbabwe used integrated outreach services that brought treatments to patients, especially those who could not visit health centers due to lockdowns or travel problems. This helped keep medicine access steady even when fewer people used health services.
U.S. medical practices might find it useful to set up or expand remote patient monitoring, home medicine delivery, and mobile health clinics. These methods reduce the number of patients at central facilities and help maintain care during emergencies.
Zimbabwe’s experience shows that fixing healthcare supply chains needs more than just pooled buying. Efforts must include making products locally, trade rules, and logistics.
For U.S. healthcare leaders, this means joining policy talks and pushing for better infrastructure that supports local production. Having more domestic manufacturing, varied sourcing, and flexible import rules is important to build strong supply systems.
Modern health systems can use technology like artificial intelligence (AI) and automation to become stronger.
In the U.S., AI-driven workflow automation can help improve procurement and supply tasks by:
AI and automation make healthcare systems run more smoothly and reliably. U.S. clinics and hospitals should think about adding these tools to supply and patient care tasks to be better prepared.
The problems Zimbabwe faced during COVID-19 are common in healthcare during global emergencies. U.S. medical practice leaders should:
Learning from Zimbabwe’s challenges, which were also seen in the U.S., can help healthcare leaders make their systems stronger for future emergencies.
The COVID-19 pandemic showed weaknesses in healthcare supply chains worldwide. Zimbabwe’s experience revealed how existing resource problems grew worse with export restrictions, shipping issues, and fewer suppliers. Pooled procurement and integrated service delivery were key ways to keep medicine access during the crisis.
U.S. healthcare leaders can learn from this by improving buying strategies, using supply chain technology, and working together regionally to be more resilient. Technologies like AI workflow automation and automated phone systems can help healthcare run better and keep patient care steady when times are uncertain.
Building healthcare strength takes careful planning, supportive policies, and new technology. Keeping these lessons in mind will help U.S. medical practices get ready for future global health problems.
The pandemic disrupted supply chains, leading to increased medicine shortages, export restrictions, and logistical difficulties that exacerbated pre-existing resource constraints.
The study conducted semistructured in-depth key informant interviews with 36 stakeholders in Zimbabwe’s health system, including pharmacists and procurement professionals.
Initially, price increases were observed for internationally shipped medicines and personal protective equipment due to additional freight costs.
Health systems adapted by modifying treatment regimens, adjusting dispensing schedules, redistributing stock among facilities, and developing new integrated outreach service models.
The COVID-19 pandemic led to reduced patient demand and lower health services utilization, which helped moderate some supply shocks and price volatility.
Pooled procurement, especially at regional and global levels, can enhance resilience by ensuring continuity of access to health services and products during crises.
Respondents highlighted resource constraints, medicine shortages, currency shortages, and inefficiencies in the supply chain as persistent issues before the pandemic.
The pandemic saw reduced participation from international suppliers in competitive bidding and tendering processes, further straining procurement.
Policies should focus on avoiding blanket restrictions on medical product exports and imports and fostering long-term service agreements for better supply stability.
Interventions across manufacturing, trade, regulatory policy, and service delivery are essential to build resilient supply chains capable of withstanding future disruptions.